头孢曲松钠联合利福霉素钠治疗小儿大叶性肺炎的临床效果研究

Research of Clinical Effect of Ceftriaxone Sodium Combined with Rifamycin Sodium Treatment on Lobar Pneumonia in Children

探讨头孢曲松钠、利福霉素钠共同应用于小儿大叶性肺炎的临床效果。选取漯河市儿童医院收治的48例大叶性肺炎典型患儿为研究对象,按统计学分类,随机分为对照组和试验组,每组各24例。对照组用头孢曲松钠治疗,试验组在对照组的基础上同时加用利福霉素钠,通过对比分析两组患儿的临床疗效以及炎症反应指标血清C反应蛋白(CRP)和乳酸脱氢酶(LDH)的变化情况,以此判断患儿病情恢复情况。计算两组的好转率、对比分析试验组和对照组的CRP、LDH数据差异(P<0.05),实验结果具有显著性差异。在治疗小儿大叶性肺炎中,头孢曲松钠联合利福霉素钠优于头孢曲松钠,可有效降低患儿的炎症反应。

The research explores the clinical effect of ceftriaxone sodium combined with rifamycin sodium treatment on lobar pneumonia in children.48 children with lobar pneumonia in Luohe Children’s Hospital are selected as the research objects.According to statistics classification,they are randomly divided into control group and experimental group,with 24 cases in each group.Control group receive cefrtiacone sodium treatment,and based on this,experimental group receive rifamycin sodium treatment.Through comparative analysis,clinical effects and inflammatory response change situation,such as serum CRP and LDH of two groups are compared to determine the recovery situation of the children.Improvement rates of two groups are calculated,and the data differences of CRP and LDH of the experimental group and control group are analyzed(P<0.05).There is statistically significant difference in experimental results.In the treatment of lobar pneumonia in children,the clinical effect of ceftriaxone sodium combined with rifamycin sodium is better than ceftriaxone sodium only.It can effectively decrease the children’s inflammatory response.